Related Experiment Video
Updated: Apr 20, 2026

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
The management of residual or recurrent central neurocytoma
Jayesh P Thawani1, John Y K Lee2
1Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, 3 Silverstein Building, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Abstract:
Treatment following neurosurgical resection or biopsy of a central neurocytoma depends on the pathologic analysis and proliferative activity demonstrated, the extent of surgical resection, the neuroanatomic location and accessibility of residual tumor, and the patient's postoperative condition. The risks and benefits of additional surgery, radiation therapy, and/or chemotherapy should be weighed and individualized based on these factors and guided by the existing literature.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers

